Related Experiment Videos
Antiangiogenic potential of 10-hydroxycamptothecin
1Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Science, Chinese Academy of Sciences, PR China.
Life Sciences
|October 9, 2001
Summary
10-hydroxycamptothecin (HCPT) demonstrated potent antiangiogenic and cytotoxic effects by inhibiting endothelial cell proliferation, migration, and tube formation. This compound also induced apoptosis in human microvascular endothelial cells, warranting further investigation as a potential anti-cancer drug.
Area of Science:
- Pharmacology
- Cell Biology
- Oncology
Background:
- Angiogenesis is crucial for tumor growth and metastasis.
- Developing effective antiangiogenic therapies is a key strategy in cancer treatment.
Purpose of the Study:
- To evaluate the antiangiogenic and cytotoxic potential of 10-hydroxycamptothecin (HCPT).
- To investigate the effects of HCPT on human microvascular endothelial cells (HMEC) and tumor cell lines.
- To assess HCPT's mechanism of action, including apoptosis induction.
Main Methods:
- In vitro assays: SRB assay for proliferation, endothelial cell migration, and tube formation assays.
- In vivo assay: Chick embryo chorioallantoic membrane (CAM) assay for angiogenesis inhibition.
- Apoptosis assessment: Fluorescence microscopy for morphological changes.
Main Results:
- HCPT dose-dependently inhibited HMEC proliferation, migration, and tube formation.
- HCPT significantly inhibited angiogenesis in the CAM assay at low concentrations.
- HCPT induced apoptosis in HMEC cells, characterized by chromatin condensation and nuclear fragmentation.
Conclusions:
- HCPT exhibits significant in vitro and in vivo antiangiogenic activity.
- The antiangiogenic effect of HCPT is associated with the induction of apoptosis.
- HCPT shows promise as a potent antiangiogenetic and cytotoxic drug for further research.